Key points are not available for this paper at this time.
LYSERGIC acid diethylamide (LSD) has come to be regarded with interest in recent years because of its ability to produce hallucinations and other psychotic disturbances when administered to human subjects in exceedingly small doses.* Its activity in amounts of the order of 0.5 γ per kilogram of body weight suggests that it may act as an antimetabolite at a specific site and on a specific enzyme system. In this paper we wish particularly to consider effects of LSD on aspects of phosphorus metabolism and to compare these data with similar properties in schizophrenic patients. URINARY INORGANIC PHOSPHATE CHANGES IN RELATION TO ADRENOCORTICAL FUNCTION IN NORMAL MEN AND IN SCHIZOPHRENIC PATIENTS In a series of studies from the Worcester Foundation carried out in collaboration with the Worcester State Hospital, Pincus, Hoagland, and associates † have reported certain abnormalities in phosphorus metabolism of schizophrenic patients, particularly in relation to the action of
Hudson Hoagland (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: